Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,405 papers from all fields of science
Search
Sign In
Create Free Account
L 657925
Known as:
L-657925
, L657925
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Carbazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Characterization of signal transduction events stimulated by 8-epi-prostaglandin(PG)F2 alpha in rat aortic rings.
R. S. Wagner
,
C. Weare
,
N. Jin
,
E. Mohler
,
R. Rhoades
Prostaglandins
1997
Corpus ID: 35749252
1996
1996
Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclase.
R. V. Paul
,
H. Saxenhofer
,
P. Wackym
,
P. Halushka
American Journal of Physiology
1996
Corpus ID: 23414946
Thromboxane A2 (TxA2) participates in the pathogenesis of clinical and experimental glomerular disease. We performed radioligand…
Expand
1991
1991
Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Atsushi Masuda
,
D. Mais
,
J. Oatis
,
P. V. Halushka
Biochemical Pharmacology
1991
Corpus ID: 38257370
1991
1991
Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
P. Mayeux
,
T. Morinelli
,
+5 authors
P. V. Halushka
Journal of Biological Chemistry
1991
Corpus ID: 2907217
The effects of changes in pH on the binding of agonists and antagonists to the human platelet thromboxane A2/prostaglandin H2…
Expand
1990
1990
Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells.
T. Morinelli
,
D. Mais
,
J. Oatis
,
A. Crumbley
,
P. V. Halushka
Life Science
1990
Corpus ID: 27810082
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE